You are here: Industry Insights > cipla

News List

Cipla posts Rs 435 cr profit at Q2 expressbpd
November 08, 2017
Cipla reported a consolidated net profit of Rs. 434.95 crore for the second quarter ended September.
Cipla’s US Subsidiary receives US FDA for generic Renvela tabs expressbpd
October 27, 2017
The tablets are indicated for the control of serum phosphorus in adults with chronic kidney disease (CKD) on dialysis
Cipla launches nicotex nicotine patch expressbpd
August 22, 2017
It reduces the urge to smoke and in turn help people give up the habit of smoking
Cipla USA in collaboration with MEDRx financialexpress
April 10, 2017
Cipla’s wholly-owned subsidiary in the US — Cipla USA has signed a worldwide licensing agreement (except for East Asia) with MEDRx Company (MEDRx) to further develop and commercialise MRX-4TZT, a Tizanidine1 patch for the management of Spasticity.
Cipla receives US FDA approval for generic Epzicom tabs financialexpress
April 06, 2017
The tablets in combination with other antiretroviral agents are used for the treatment of HIV-1 infection
Cipla to divest its animal health business in South Africa and Sub-Saharan Africa expressbpd
March 07, 2017
Enters into an agreement through its wholly-owned subsidiary Inyanga Trading 386 Proprietary, with the group companies of Ascendis Health, South Africa
Cipla halts HIV drug production due to delayed government funding pharmafile
March 07, 2017
Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to...
Cipla to divest its animal health business in South Africa and Sub-Saharan Africa expressbpd
March 06, 2017
Enters into an agreement through its wholly-owned subsidiary Inyanga Trading 386 Proprietary, with the...

Previous page 1 2 3 4 5 6 7 8 Next page